- Stocks
- Healthcare
- NASDAQ: CELU

Price (delayed)

$7.97

Market cap

$947.23M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$12.08

Enterprise value

$940.05M

The gross profit is down by 40% year-on-year but it is up by 15% since the previous quarter

CELU's revenue is down by 33% year-on-year but it is up by 19% since the previous quarter

The quick ratio has dropped by 54% year-on-year and by 36% since the previous quarter

The company's net income fell by 40% QoQ and by 20% YoY

Sector: Healthcare

Industry: Biotechnology

What are the main financial stats of CELU

Market
Valuations
Earnings

Shares outstanding

118.85M

Market cap

$947.23M

Enterprise value

$940.05M

Price to earnings (P/E)

N/A

Price to book (P/B)

N/A

Price to sales (P/S)

11.29

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

55.5

Revenue

$16.94M

EBIT

-$292.66M

EBITDA

-$282.55M

Free cash flow

-$117.04M

Per share
Balance sheet
Liquidity

EPS

-$12.08

Free cash flow per share

-$4.88

Book value per share

-$17.03

Revenue per share

$0.71

TBVPS

$6.54

Total assets

$405.11M

Total liabilities

$466.93M

Debt

$30.93M

Equity

-$611.93M

Working capital

$17.96M

Debt to equity

-0.05

Current ratio

1.73

Quick ratio

1.81

Net debt/EBITDA

0.03

Margins
Efficiency
Dividend

EBITDA margin

-1,668.2%

Gross margin

63.5%

Net margin

-1,716.8%

Operating margin

-1,363.7%

Return on assets

-81.9%

Return on equity

N/A

Return on invested capital

-141.9%

Return on capital employed

-76.9%

Return on sales

-1,727.9%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Celularity stock price performed over time

Intraday

-8.07%

1 week

-9.43%

1 month

-21.79%

1 year

-22.62%

YTD

-27.55%

QTD

-21.71%

How have Celularity's revenue and profit performed over time

Revenue

$16.94M

Gross profit

$10.76M

Operating income

-$230.99M

Net income

-$290.8M

Gross margin

63.5%

Net margin

-1,716.8%

CELU's net margin has dropped by 80% year-on-year and by 18% since the previous quarter

Celularity's operating margin has shrunk by 61% YoY but it has increased by 6% QoQ

The company's net income fell by 40% QoQ and by 20% YoY

The gross profit is down by 40% year-on-year but it is up by 15% since the previous quarter

What is Celularity's growth rate over time

What is Celularity stock price valuation

P/E

N/A

P/B

N/A

P/S

11.29

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

55.5

Celularity's EPS has decreased by 39% QoQ and by 19% YoY

CELU's equity is down by 15% since the previous quarter

CELU's revenue is down by 33% year-on-year but it is up by 19% since the previous quarter

CELU's P/S is 23% above its last 4 quarters average of 10.0

How efficient is Celularity business performance

CELU's return on invested capital has dropped by 67% since the previous quarter and by 12% year-on-year

Celularity's return on sales has decreased by 45% YoY and by 17% QoQ

CELU's ROA is down by 29% since the previous quarter and by 18% year-on-year

What is CELU's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for CELU.

How did Celularity financials performed over time

CELU's total assets is 13% smaller than its total liabilities

Celularity's current ratio has shrunk by 64% YoY and by 36% QoQ

The quick ratio has dropped by 54% year-on-year and by 36% since the previous quarter

CELU's debt is 105% greater than its equity

The debt to equity has grown by 17% from the previous quarter

CELU's equity is down by 15% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.